The 18F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer

被引:0
作者
Mihailovic, Jasna [1 ,2 ]
Ubavic, Milan [3 ,4 ]
机构
[1] Oncol Inst Vojvodina, Dept Nucl Med, Put Dr Goldmana 4, Sremska Kamenica 21000, Serbia
[2] Univ Novi Sad, Tech Fac Mihajlo Pupin, Zrenjanin, Serbia
[3] Univ Novi Sad, Lab Diagnost Medlab, Hlth Care Inst, Novi Sad, Serbia
[4] European Univ, Fac Pharm, Novi Sad, Serbia
关键词
breast neoplasms; tomography; emission-computed; x-ray computed; radiopharmaceuticals; sensitivity and specificity; STANDARDIZED UPTAKE VALUES; LYMPH-NODE BIOPSY; F-18; FDG-PET; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; INITIAL-EXPERIENCE; GLUCOSE-METABOLISM; BONE METASTASES; RECEPTOR STATUS; EARLY RESPONSE;
D O I
10.2298/VSP151018110M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:571 / 580
页数:10
相关论文
共 83 条
[21]   Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy [J].
Chen, XM ;
Moore, MO ;
Lehman, CD ;
Mankoff, DA ;
Lawton, TJ ;
Peacock, S ;
Schubert, EK ;
Livingston, RB .
ACADEMIC RADIOLOGY, 2004, 11 (10) :1115-1124
[22]   [18F]-3′Deoxy-3′-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel [J].
Contractor, Kaiyumars B. ;
Kenny, Laura M. ;
Stebbing, Justin ;
Rosso, Lula ;
Ahmad, Rizvana ;
Jacob, Jimmy ;
Challapalli, Amarnath ;
Turkheimer, Federico ;
Al-Nahhas, Adil ;
Sharma, Rohini ;
Coombes, R. Charles ;
Aboagye, Eric O. .
CLINICAL CANCER RESEARCH, 2011, 17 (24) :7664-7672
[23]   Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis [J].
Cooper, K. L. ;
Harnan, S. ;
Meng, Y. ;
Ward, S. E. ;
Fitzgerald, P. ;
Papaioannou, D. ;
Wyld, L. ;
Ingram, C. ;
Wilkinson, I. D. ;
Lorenz, E. .
EJSO, 2011, 37 (03) :187-198
[24]   Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer:: a preliminary observation [J].
Crippa, F ;
Seregni, E ;
Agresti, R ;
Chiesa, C ;
Pascali, C ;
Bogni, A ;
Decise, D ;
De Sanctis, V ;
Greco, M ;
Daidone, MG ;
Bombardieri, E .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (10) :1429-1434
[25]   The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer [J].
Danforth, DN ;
Aloj, L ;
Carrasquillo, JA ;
Bacharach, SL ;
Chow, C ;
Zujewski, J ;
Whatley, M ;
Galen, B ;
Merino, M ;
Neumann, RD .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 75 (02) :135-146
[26]   Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer [J].
Dirisamer, Albert ;
Halpern, Benjamin S. ;
Floery, Daniel ;
Wolf, Florian ;
Beheshti, Mohsen ;
Mayerhoefer, Marius E. ;
Langsteger, Werner .
EUROPEAN JOURNAL OF RADIOLOGY, 2010, 73 (02) :294-299
[27]   3′-Deoxy-3′-[18F]fluorothymidine (FLT) uptake in breast cancer cells as a measure of proliferation after doxorubicin and docetaxel treatment [J].
Dittmann, Helmut ;
Jusufoska, Ajnur ;
Dohmen, Bernhard Matthias ;
Smyezek-Gargya, Brigitte ;
Fersis, Nikos ;
Pritzkow, Maren ;
Kehlbach, Rainer ;
Vonthein, Reinhard ;
Machulla, Hans Juergen ;
Bares, Roland .
NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (02) :163-169
[28]   Imaging of oncologic patients: Benefit of combined CT and FDG PET in the diagnosis of malignancy [J].
Eubank, WB ;
Mankoff, DA ;
Schmiedl, UP ;
Winter, TC ;
Fisher, ER ;
Olshen, AB ;
Graham, MM ;
Eary, JF .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 171 (04) :1103-1110
[29]   Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer [J].
Eubank, WB ;
Mankoff, D ;
Bhattacharya, M ;
Gralow, J ;
Linden, H ;
Ellis, G ;
Lindsley, S ;
Austin-Seymour, M ;
Livingston, R .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (02) :479-486
[30]  
Even-Sapir E, 2004, J NUCL MED, V45, P272